Morgan Stanley Downgrades Inspire Pharmaceuticals (ISPH) to Underweight
Morgan Stanley downgrades Inspire Pharmaceuticals (Nasdaq: ISPH) from Equalweight to Underweight.
Inspire Pharmaceuticals, Inc. (Inspire) is a biopharmaceutical company focusing on discovering, developing and commercializing prescription pharmaceutical products in disease areas with commercial potential or unmet medical needs.
Related Categories
DowngradesStocks Mentioned
Related Entities
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
